机构地区:[1]宁夏医科大学临床医学院,宁夏银川750004 [2]宁夏医科大学总医院妇科,宁夏银川750004 [3]福建医科大学妇儿临床医学院,福建福州350001 [4]灵武市人民医院妇产科,宁夏灵武750499 [5]西安医学院第一附属医院妇科,陕西西安710077 [6]宁夏医科大学生育力保持教育部重点实验室,宁夏银川750004
出 处:《新乡医学院学报》2023年第3期224-229,共6页Journal of Xinxiang Medical University
基 金:宁夏回族自治区中央引导地方科技发展专项(编号:2022FRD05034);宁夏自然科学基金资助项目(编号:2021A1337,2022AAC03493)。
摘 要:目的探讨经阴道三维超声检测最大肿瘤直径(MTD)联合外周血鳞状上皮细胞癌抗原(SCC-Ag)水平对局部晚期及晚期宫颈癌的诊断价值。方法选择2020年10月至2022年1月宁夏医科大学总医院收治的204例宫颈癌患者为研究对象。年龄26~80(51.82±11.00)岁;国际妇产科联盟(FIGO)分期≤ⅡA期130例,≥ⅡB期74例;宫颈鳞状细胞癌166例,非鳞状细胞癌38例;低/中分化58例,高分化146例。采用经阴道三维超声检测患者首次诊断时的MTD,免疫化学发光法检测治疗前患者外周血SCC-Ag水平。比较不同FIGO分期、组织类型、分化程度患者的MTD及外周血SCC-Ag水平,分析MTD、SCC-Ag与宫颈癌FIGO分期、组织类型、分化程度的相关性;采用受试者操作特征(ROC)曲线分析MTD、SCC-Ag单独和联合对≥ⅡB期宫颈癌的诊断效能。结果≥ⅡB期组患者的外周血SCC-Ag水平显著高于≤ⅡA期组,MTD显著大于≤ⅡA期组(P<0.05)。鳞状细胞癌组患者的外周血SCC-Ag水平显著高于非鳞状细胞癌组(P<0.05);非鳞状细胞癌组患者SCC-Ag阳性13例(34.2%),鳞状细胞癌组患者SCC-Ag阳性111例(66.9%),非鳞状细胞癌组患者SCC-Ag阳性率显著低于鳞癌组(χ^(2)=13.834,P<0.05)。鳞状细胞癌组与非鳞状细胞癌组患者的MTD比较差异无统计学意义(P>0.05)。低/中分化组患者的MTD显著大于高分化组(P<0.05),2组患者的外周血SCC-Ag水平比较差异无统计学意义(P>0.05)。SCC-Ag、MTD与FIGO分期呈正相关(r=0.484、0.544,P<0.05);MTD与分化程度呈负相关(r=-0.166,P<0.05),SCC-Ag与分化程度无相关性(r=-0.027,P>0.05)。SCC-Ag、MTD单独诊断≥ⅡB期宫颈癌的ROC曲线下面积(AUC)分别为0.790、0.824,SCC-Ag与MTD联合诊断≥ⅡB期宫颈癌的AUC为0.855;SCC-Ag联合MTD诊断≥ⅡB期宫颈癌的AUC显著大于单独SCC-Ag、MTD诊断(Z=1.956、2.152,P<0.05);单独SCC-Ag与单独MTD诊断≥ⅡB期宫颈癌的AUC比较差异无统计学意义(Z=0.789,P>0.05)。结论宫颈癌患者�Objective To investigate the diagnostic value of maximum tumor diameter(MTD)detected by three-dimensional transvaginal ultrasound combined with peripheral blood squamous cell carcinoma antigen(SCC-Ag)for locally advanced and advanced cervical cancer.Methods A total of 204 cervical cancer patients admitted to the General Hospital of Ningxia Medical University from October 2020 to January 2022 were selected as the research subjects.They were aged 26-80(51.82±11.00)years;the Federation International of Gynecology and Obstetrics(FIGO)stage of 130 cases were of≤stageⅡA,and 74 cases were of≥stageⅡB;there were 166 cases of cervical squamous cell carcinoma,38 cases of non-squamous cell carcinoma;there were 58 cases with low/medium differentiation,146 cases with high differentiation.MTD was detected by three-dimensional vaginal ultrasound at the patient′s first diagnosis,and the SCC-Ag level in peripheral blood of the patients before treatment was detected by immunochemiluminescence.The MTD and SCC-Ag levels in peripheral blood of patients with different FIGO stages,tissue types and differentiation degree were compared,and the correlations between MTD,SCC-Ag and cervical cancer FIGO stage,tissue type and differentiation degree were analyzed.The diagnostic efficacy of MTD,SCC-Ag single and in combination for stage≥ⅡB cervical cancer was analyzed by receiver operating characteristic(ROC)curve.Results The SCC-Ag level in peripheral blood of patients in the stage≥ⅡB group was significantly higher than that in the stage≤ⅡA group,and the MTD was significantly larger than that in the stage≤ⅡA group(P<0.05).The SCC-Ag level in peripheral blood of patients in the squamous cell carcinoma group was significantly higher than that in the non-squamous cell carcinoma group(P<0.05).The positive SCC-Ag was 13 patients(34.2%)in the non-squamous cell carcinoma group,111 patients(66.9%)in the squamous cell carcinoma group,and the positive rate of SCC-Ag of patients in the non-squamous cell carcinoma group was signi
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...